Dr. Wei-Mei Ching

Dr. Wei-Mei Ching serves as Principal Investigator at the Naval Medical Research Center, where she leads high-priority biomedical research initiatives critical to force health protection and operational readiness. In this role, she defines scientific requirements, oversees technical evaluations, and collaborates closely with contracting personnel to ensure acquisitions align with mission-critical needs in infectious disease diagnostics, field-deployable medical technologies, and laboratory-based analytical systems. Her procurement activities are centered on research and development contracts supporting rapid diagnostic innovation, biosensor development, and point-of-care testing platforms tailored for austere military environments. Dr. Ching maintains a sustained working relationship with REES SCIENTIFIC CORPORATION, a trusted partner in the development and validation of specialized diagnostic tools and biomedical instrumentation. Her contracting patterns reflect a preference for established technical collaborators with proven expertise in military-relevant medical innovation, indicating a reliance on vendors capable of delivering complex, high-integrity R&D solutions under stringent performance and timeline constraints. These partnerships are characterized by iterative technical collaboration, rigorous validation protocols, and long-term project continuity. Dr. Ching’s procurement portfolio reflects no set-aside preferences, with all awards issued under full and open competition. This indicates a prioritization of technical capability and mission readiness over socioeconomic targeting, consistent with the specialized nature of her research domain where only a limited pool of vendors possess the requisite expertise in biosurveillance, pathogen detection, and deployable diagnostics. Her technical focus lies in R&D services for biomedical diagnostics, infectious disease surveillance, and laboratory automation—domains aligned with NAICS categories such as 541715 (Research and Development in Biotechnology) and 541712 (Research and Development in Physical, Engineering, and Life Sciences). She procures advanced analytical instruments, molecular diagnostic kits, and integrated monitoring systems designed for use in expeditionary and shipboard settings, demonstrating deep expertise in translational medical science and defense health innovation.